What are the histopathological features of Erythema Annulare Centrifugum (EAC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Histopathological Features of Erythema Annulare Centrifugum

Erythema annulare centrifugum (EAC) is classified histopathologically into two distinct types—superficial and deep—with the superficial type being far more common (78% of cases) and characterized by a tight perivascular lymphocytic infiltrate in the superficial dermis with overlying parakeratosis and spongiosis, while the deep type shows a dense perivascular and periadnexal lymphocytic infiltrate ("coat-sleeve" pattern) in the mid-to-deep dermis without epidermal changes. 1

Superficial Type (Most Common - 78% of Cases)

The superficial variant demonstrates the following key features 1:

  • Tight perivascular lymphocytic infiltrate confined to the superficial (papillary) dermis surrounding dilated capillaries 1
  • Epidermal changes including parakeratosis (abnormal retention of nuclei in the stratum corneum) and spongiosis (intercellular edema) 1
  • Scaling clinically correlates with the parakeratotic epidermis seen histologically 1

Deep Type (Less Common - 22% of Cases)

The deep variant shows distinct histological patterns 1:

  • Dense perivascular and periadnexal lymphocytic infiltrate in the mid-to-deep reticular dermis, creating the characteristic "coat-sleeve" or "cuffing" pattern around vessels and adnexal structures 1
  • Absence of epidermal changes—no parakeratosis or spongiosis, which explains the lack of scale clinically in this variant 1
  • Deeper dermal involvement extending well below the papillary dermis 1

Important Diagnostic Considerations

The diagnosis of EAC should prompt re-evaluation because recent evidence demonstrates that "EAC" functions as a clinical reaction pattern rather than a specific disease entity, with 78% of cases actually representing other conditions including lupus erythematosus (32%), spongiotic dermatitides (28%), or pseudolymphoma (18%). 2

Critical Pitfall to Avoid

When encountering a histological pattern labeled as "EAC," consider these alternative diagnoses 2:

  • Tumid lupus erythematosus (32% of cases clinically diagnosed as EAC)—look for mucin deposition and deeper dermal lymphocytic infiltrates 2
  • Spongiotic dermatitis (28% of cases)—distinguished by prominent spongiosis and eosinophils 2
  • Pseudolymphoma/cutaneous Lyme disease (18% of cases)—in pseudolymphomatous patterns, spirochetes were identified in 81% of cases by focus-floating microscopy and confirmed by Borrelia-specific PCR in 67% 2

Additional Histological Clues

The histopathological examination should specifically assess 2:

  • Mucin deposition (suggests lupus erythematosus rather than true EAC) 2
  • Eosinophils in the infiltrate (points toward spongiotic dermatitis) 2
  • Spirochetes using focus-floating microscopy or Borrelia PCR if pseudolymphomatous pattern is present, as this may represent cutaneous Lyme disease 2

Clinical-Pathological Correlation

The presence or absence of scale clinically correlates directly with histological type 1:

  • Scaly plaques = superficial type with parakeratosis 1
  • Non-scaly plaques = deep type without epidermal involvement 1

Related Questions

What is the updated protocol for diagnosis and management of erythema annulare centrifugum (EAC)?
What is the initial management for a patient presenting with Erythema annulare (ring-shaped erythema)?
Is there a connection between erythema annulare centrifugum and ENA (Extractable Nuclear Antigen)-SS-A (Sjögren's syndrome antigen) autoantibody positivity?
What is the management and diagnosis of a 48-year-old woman with a 4-week history of pruritus and erythematous papules on both lower legs unresponsive to topical corticosteroids (corticosteroids) and antihistamines (antihistamines)?
What is the differential diagnosis for a skin inflammatory process consisting of painful annular lesions, 3 to 6 cm in diameter, without central clearing, with some lesions having slight pus collection?
What is the next line of management and investigation for a patient with severe anemia (hemoglobin level of 2.9) barger) and a platelet count (plt) of 130,000?
What is the recommended dosage of normal saline (sodium chloride 0.9%) nasal spray for a patient with a viral infection?
What is the best approach to evaluate chest pain in an adult patient with an atrial septal defect (ASD)?
How do you differentiate normal forgetfulness from dementia in a young male in his late 20s presenting with concerns about forgetfulness?
When is Mounjaro (tirzepatide) not indicated for use in patients with a history of pancreatitis, thyroid cancer, or multiple endocrine neoplasia syndrome type 2?
What is the recommended treatment for a patient with rosacea?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.